The Global CT Scanner Market is projected to reach USD 6.20 Billion by 2022

Major factors driving the growth of this market include growing need for effective and early diagnosis, rising global prevalence of targeted diseases coupled with an aging population, increasing preference for minimally invasive diagnostic procedures, increasing benefits of CT scans over other imaging modalities, and technological advancements. However, significant installation and maintenance costs, uncertain reimbursement scenario across developing nations, dearth of well-trained and skilled healthcare professionals may hinder the growth of the CT scanner market during the forecast period.

The Global CT Scanner Market is projected to reach USD 6.20 Billion by 2022, at a CAGR of 5.4% during the forecast period.

Download PDF Brochure: - http://www.marketsandmarkets.com/pdfdownload.asp?id=184364345

Major Market Developments:

• In 2017, GE Healthcare introduced a dedicated cardiovascular CT system, namely, CardioGraphe which creates 3D images of coronaries, valves, chambers and myocardium in one heartbeat.
• In 2017, Toshiba, signed a three-year pricing agreement with Varex Imaging Corporation in order to supply CT tubes for integration into Toshiba’s CT systems
• In 2017, Siemens signed an agreement with HeartFlow for the integration of Siemens’s CT scanner systems with HeartFlow’s FFRct Analysis.
• In 2017, Hiatchi, signed an agreement with Redlen Technologies for the development of a multi-energy photon-counting Computed tomography (PCCT) semiconductor detector module

On the basis of technology, the CT scanners market is segmented into high-slice CT, mid-slice CT, low-slice CT, and cone beam CT technology. The cone beam CT technology segment is expected to grow faster than the other segments during the forecast period, majorly due to factors like procedural advantages; rising market demand for cosmetic dentistry; and ongoing product development & commercialization across major healthcare markets.
Based on type, the CT scanners market is divided into stationary and portable CT scanners. Portable CT scanners segment is poised to grow faster than the other segment due to increasing number of device installations across major markets, growing application horizons, and the lower switching costs provided by portable CT scanners.

Geographical Analysis:-                

Geographically, the CT scanner market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America accounted for the largest share of the market in 2017, which is primarily driven by growth in the aging U.S. population; an increasing public emphasis on minimally invasive & effective disease management strategies; robust reimbursement scenario; increasing adoption of novel applications; and rising public-private investments.

Read more: - https://www.marketsandmarkets.com/PressReleases/ct-scanner.asp

Top Key players:-
The major players in the CT scanner market are Koninklijke Philips N.V. (Netherlands), GE Healthcare (U.S.), Toshiba Corporation (Japan), Siemens AG (Germany), Hitachi Ltd. (Japan), Shimadzu Corporation (Japan), Samsung Electronics Co., Ltd. (South Korea), Neusoft Medical Systems Co., Ltd. (China), Medtronic plc (Ireland), Shenzhen Anke High-tech Co., Ltd. (Hong Kong), Accuray Incorporated (U.S.), PlanMED (Finland), Koning Corporation (U.S.), Carestream Health Inc. (U.S.), and PointNix Co. Ltd (South Korea).

Animal Wound Care Market by Product, Advanced, Animal & End User - Global Forecast to 2021

The growth in this market is majorly attributed to factors such as rising pet adoption, increasing number of veterinary practitioners and rise in their income levels in developed economies, rising demand for pet insurance coupled with growing animal health expenditure, and rising awareness about animal health.

The Animal Wound Care Market witnessed healthy growth during the last decade and is expected to grow at a CAGR of 6.7% between 2016 and 2021 to reach 1,134.0 Million by 2021.

Major Market Developments:-

• In November 2015, Ethicon, Inc. (US) signed an agreement with Elanco Animal Health (US) to market Ethicon veterinary sutures. This agreement helped the company to strengthen its geographical presence.
• In June 2015, Henry Schein, Inc. (US), leading provider of healthcare products and services to animal health and medical practitioners, acquired 85% shares of Jorgen KRUUSE A/S. This acquisition helped Henry to expand its animal health portfolio in Nordic countries and helped KRUUSE to widen its geographical reach across the globe.
• In January 2014, Bayer AG (Germany) launched Remend, a wound spray gel to manage wounds of dogs and cats. This launch expanded the company’s wound care product portfolio.

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=253831778
The global animal wound care market is segmented based on product, animal type, end user, and geography.

Based on product type, the market is segmented into surgical wound care products, advanced wound care products, traditional wound care products, and therapy devices. Based on animal type, the market is segmented into companion animals and livestock animals. On the basis of end-users, the global animal wound care market is segmented into hospitals & clinics and home care. Similarly, on the basis of geography, the animal wound care market is segmented into North-America, Europe, Asia-Pacific, and Rest of the World.

In 2015, surgical wound care product segment accounted for the largest share of the global animal wound care.  The large share is mainly attributed to greater adoption of these products in hospitals and clinics for wound healing, rising incidence of wounds in pets, and increasing number of surgeries.

The companion animals segment accounted for the largest share of the animal wound care market and is expected to grow at a highest CAGR in the forecasted period. The large share and high growth of this segment can mainly be attributed to the growing companion animal population, increasing pet care expenditure, and growing demand for pet insurance across the globe. The hospitals and clinics accounted for the largest market share of the animal wound care market and is expected to grow at a higher CAGR in next five years.

Regional Analysis:-
North America is the largest regional segment for animal wound care owing to the well-established animal healthcare market. The largest share of this regional segment is driven by growing pet adoption, increasing number of veterinary conditions requiring surgeries, rising animal healthcare expenditure, and growing number of veterinary practitioners and their income levels.

Read More: - https://www.marketsandmarkets.com/PressReleases/animal-wound-care.asp

Key Players:-
The market players, namely, B Braun Melsungen AG (Germany), Medtronic plc (Ireland), 3M Company (U.S.), and Ethicon Inc. (U.S.) held the major share of the animal wound care market and will continue to dominate the market between 2016 and 2021. Some of the major players operating in this market are Virbac (France), Jorgen Kruuse A/S (Denmark), Neogen Corporation (U.S.), Acelity L.P. Inc. (U.S.), Bayer AG (Germany), Advancis Veterinary Ltd. (U.K), and Robinson Healthcare Limited (U.K.).

Growth opportunities of Needles Market

These needles are used for injecting the drug into the subcutaneous layer; this enables the quick absorption of active compounds into the bloodstream, which is a key factor contributing to the market growth of this segment.

Key factors such growing geriatric population, increasing number of hospitals in emerging markets, and high prevalence of chronic diseases is the major factors driving the growth of the Needles Market across the globe.

This report studies the global Needles Market over the forecast period of 2017 to 2022. The market is expected to reach USD 8.47 Billion by 2022, at CAGR of 7.8% during the forecast period.           
On the basis of type, the global needles market is segmented into two broad categories, namely, conventional needles and safety needles. The conventional needles market is estimated to command the larger share of the global needles market in 2017.

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=223979930 

Based on product, the market is segmented into suture needles, blood collection needles, ophthalmic needles, dental needles, insufflation needles, pen needles, and other needles. While the pen needles segment is expected to hold the largest share of the in 2017, it is the blood collection needles segment that is expected to grow at a significant CAGR from 2017 to 2022. Factors like the increasing number of blood donations and technological advancements in blood collection sets are driving the growth of the blood collection needles market.

The needles market is segmented into hypodermic, intravenous, intramuscular, and intraperitoneal needles on the basis of delivery mode. The hypodermic needles segment is expected to account for the largest share of the needles market in 2017.
Regional Analysis:-

As of 2016, North America held the largest share of the global needles market, followed by Europe. Its dominant share is attributed to the rising incidence of chronic diseases, initiatives by different organizations for the reduction in blood borne infections, and increasing prevalence of cardiovascular diseases.

Read more: - https://www.marketsandmarkets.com/PressReleases/needles.asp

The key players in the global needles market are Hamilton Company (U.S.), Medtronic plc (Ireland), Becton, Dickinson and Company (U.S.), Stryker Corporation (U.S.), B. Braun Melsungen AG (Germany), Boston Scientific Corporation (U.S.), Terumo Corporation (Japan), Novo Nordisk A/s (Denmark), Smiths Medical (U.K.), and Thermo Fisher Scientific (U.S.).

High Throughput Screening Market by Technology, Application, Product & End User - 2027

The major factors driving the growth of the HTS market include initiatives undertaken by pharmaceutical and biotechnology companies, increasing R&D spending, technological advancements in HTS, and the availability of government funding and venture capital investments.

The report "High Throughput Screening Market is expected to reach USD 29.29 billion by 2027 from an estimated USD 14.95 billion in 2019, at a CAGR of 7.8%.

HTS Market Drivers: -                  1Growing Adoption of Open Innovation Models in Pharmaceutical and    Biotechnology Companies
                 2 Government Funding and Venture Capital Investments
                 3 Increasing R&D Spending
                 4 Technological Advancements

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=134981950

The report analyzes the global HTS market by product & service, technology, application, end user, and region. On the basis of product & service, the reagents & assay kits segment accounted for the largest share of the global HTS market in 2017. Factors such as the large numbers of reagents and assay kits used in HTS techniques, rising prevalence of a number of diseases, increasing pharmaceutical R&D, and increased government funding for life science research are driving the growth of this segments.

Geographic Analysis

• Further breakdown of the Rest of APAC high-throughput screening market into Australia, New Zealand, Singapore, and others
• Further breakdown of the Rest of Europe high-throughput screening market into Belgium, Russia, the Netherlands, Switzerland, and others

Read More: - https://www.marketsandmarkets.com/PressReleases/high-throughput-screening.asp

 Key players:-

The prominent players in the global HTS market are Agilent (US), Danaher (US), Thermo Fisher Scientific (US), PerkinElmer (US), Tecan (Switzerland), Axxam (Italy), Merck Group (Germany), Bio-Rad (US), Hamilton (US), Corning (US), BioTek (US), and Aurora Biomed (Canada).

New Approach towards Technological Advancements in Particle Size Analysis Market

The major factors driving the growth of the Particle Size Analysis Market include increasing research activities in the field of nanotechnology; technological advancements in particle size analyzers; increasing investment in pharmaceutical R&D; and stringent regulatory guidelines for product quality across industries.

The global Particle Size Analysis Market is expected to reach USD 524.3 Million by 2027 from USD 314.3 Million in 2017, at a CAGR of 5.2%.

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=74084833 

Market Drivers: -
            1.Increasing Research Activities in the Field of Nanotechnology
            2.Technological Advancements in Particle Size Analyzers
            3.Increasing Investments in Pharmaceutical R&D
            4.Development of Technologically Advanced Instruments Requiring Low Sample Volumes and Preparation Time
            5.Stringent Regulatory Guidelines for Product Quality across Industries
            6.Funding Activities Increasing the Purchasing Power of Research Institutions

Industry Analysis:-
Based on the type of industry, the global particle size analysis market is classified into five major segments—healthcare; chemicals and petroleum; mining, minerals, and cement; food and beverage; and other industries. The last segment comprises industries related to inks, toners, paint, coatings, cosmetics, and environmental analysis. The healthcare industry segment is expected to account for the largest share of the particle size analysis market in 2017 due to its dominance can be attributed to the increasing applications of nanotechnology in medical science, the rapid growth of pharmaceuticals in the healthcare industry.
  
Geographical Analysis:
Geographically, the market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America is expected to account for the largest share of the global particle size analysis market during the forecast period (2017-2022). The large share of this region can be attributed to the increasing government support for nanotechnology research and strict regulatory guidelines on product quality. In addition, increasing efforts by market players to expand their business in the US is one of the key factors propelling the growth of particle size analysis in North America.

Read More :- ( Particle size analysis market) : https://www.marketsandmarkets.com/PressReleases/particle-size-analysis.asp

Key Players:-
The major players operating in the particle size analysis market include Malvern Instruements Limited (UK), HORIBA, Ltd. (Japan), and Beckman Coulter, Inc. (US).

Insulin Delivery Devices Market by Type and End User - 2021

The growth of the market is attributed favorable reimbursement scenario and strong government support in selected countries, technological advancements in insulin delivery devices, and growing diabetic population. Increasing research and development activities and increase in diabetes-related health expenditure in emerging economies are expected to offer significant growth opportunities for manufacturers in the coming years.

The report Insulin Delivery Devices Market is expected to reach USD 17.8 billion by 2021 from USD 11.5 billion in 2016, at a CAGR of 9.1% during the forecast period.

Market Drivers: -
            1 Growing Diabetic Population
            2 Technological Advancements in Insulin Delivery Devices
            3 Favorable Reimbursement Environment and Government Support in Selected Countries
            4 Conferences, Meetings, and Congresses to Create Awareness About Insulin Delivery Devices

Based on type, the insulin delivery devices market is categorized into pens, pumps, pen needles, syringes, and others (insulin inhalers, transdermal patches, and insulin jet injectors, among others). In 2016, the pens segment is expected to command the largest share of the insulin delivery devices market. The pens segment is further divided into reusable and disposable pens. The reusable pens segment is estimated to command the largest share of the insulin pens market in 2016.

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=107632092

By end user, the insulin delivery devices market is segmented into patients/homecare and hospitals & clinics.  The patients/homecare segment is estimated to command the largest share of the market in 2016 and is expected to grow at the highest CAGR during the forecast period. Growth in this segment can be primarily attributed to the increasing diabetic population and rising healthcare expenditure.
In 2016, North America is expected to account for the largest share of the global insulin delivery devices market. North America’s leadership position in the market can be attributed to the rising prevalence of diabetes and favorable reimbursement scenarios in the US and Canada, awareness activities, venture capital investments and issuance of IPOs in the US, and regulations for the usage of safety-engineered needles in Canada.

During the forecast period, Asia-Pacific region is expected to register the highest growth rate. The high growth in the region can be attributed to the high adoption of insulin pens and approvals for injectable insulin in Japan, and the rising partnerships among the global and local players in Asia-Pacific countries are expected to support the growth of the Asia-Pacific insulin delivery devices market.

Read more: - https://www.marketsandmarkets.com/PressReleases/insulin-delivery-device.asp

The insulin delivery devices market is highly competitive with the presence of several small and big players. Some of the players in the insulin delivery devices market include Becton, Dickinson and Company (US), Novo Nordisk A/S (Denmark), Ypsomed Holding AG (Switzerland), Medtronic plc (Ireland), Animas Corporation (US), Tandem Diabetes Care, Inc. (US), Sanofi (France), Biocon Ltd. (India), Eli Lilly and Company (US), and Insulet Corporation (US).

Animal Antibiotics and Antimicrobials Market by Product & Mode of Delivery - Global Forecast

Factors such as increasing animal population, rising demand for animal-derived food products, increasing incidences of zoonotic diseases, implementation of regulations for preventing the spread of animal diseases, and rising demand for pet insurance and growing animal health expenditure are the major factors driving the growth of the global animal antibiotics and antimicrobials market. However, dearth of new antibiotics, growing resistance to antimicrobials and antibiotics, and replacement of routine prophylactic use of antibiotics by good husbandry and hygiene practices may hinder the growth of this market to certain extent.

The "Animal Antibiotics and Antimicrobials Market witnessed significant growth during the last decade and is expected to grow at a CAGR of 4.6% between 2016 and 2021 to reach 4.73 Billion by 2021.

The global animal antibiotics and antimicrobials market is segmented based on product, mode of delivery, animal type, and geography.

Based on product type, the market is segmented into tetracyclines, penicillins, sulfonamides, macrolides, aminoglycosides, cephalosporins, lincosamides, fluoroquinolones, and other antibiotics and antimicrobials. Based on mode of delivery, the market is further categorized into premixes, oral powders, oral solutions, injections, and other modes of delivery.

Download PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=25161353

Based on animal type, the market is segmented into food-producing animals and companion animals. The food-producing animals segment is further segmented into cattle, pigs, sheep and goats, poultry, and other food-producing animals. Similarly, on the basis of geography, the animal antibiotics and antimicrobials market is segmented into North-America, Europe, Asia-Pacific, and Rest of the World.
In 2015, the tetracyclines segment accounted for the largest share of the global animal antibiotics and antimicrobials market. However, fluoroquinolones segment is expected to witness the highest growth over the next five years. The high growth in this segment can be attributed to the advantages offered by fluoroquinolones such as higher efficacy at low concentration, quick penetration through tissues, and available variations in the route of administration.

North America is the largest regional segment for animal antibiotics and antimicrobials market owing to the well-established animal healthcare market. The largest share of this regional segment is driven by increasing demand for animal-derived food products, rising animal healthcare expenditure, growing animal population, and rising awareness about zoonotic diseases. However, the market in the Asia-Pacific region is expected to grow at the highest CAGR, owing to growing animal population, increasing demand for animal-derived food products, rising awareness regarding animal health and welfare, and growing per capita animal health expenditure, especially in India and China.

Read more:- https://www.marketsandmarkets.com/PressReleases/animal-antimicrobials-antibiotics.asp  

The market players, namely, Zoetis, Inc. (U.S.), Merck & Co., Inc. (U.S.), Bayer AG (Germany), Eli Lilly and Company (U.S.), and Virbac (France) held the major share of the animal antibiotics and antimicrobials market and will continue to dominate the market between 2016 and 2021. Some of the major players competing in this market are Zoetis, Inc. (U.S.), Bayer AG (Germany), Merck & Co., Inc. (U.S.), Eli Lilly and Company (U.S.), Virbac (France), Boehringer Ingelheim GmbH (Germany), Ceva Sante Animale (France), Vetoquinol S.A. (France), Sanofi (France), and Dechra Pharmaceuticals PLC (U.K.).

Organs-on-chips Market by Applications, Type, offering, End User - 2022

The growth of this market is mainly driven by the growing focus on developing alternatives for animal testing models, significant increase in research funding and venture capital investments for the development of organs-on-chips, technological advancements and products launches, growing number of partnerships and collaborations between pharmaceutical companies and organs-on-chips manufacturers, and growing need for early detection of drug toxicity to minimize financial losses due to late stage drug failure.

The Organs-on-chips Market is expected to reach USD 45.6 million by 2022 from USD 9.6 million in 2017, at a CAGR of 36.6%.

Market Drivers :-
                   1 Growing Focus on Developing Alternatives for Animal Testing Models
                   2 Significant Increase in Research Funding and Venture Capital Investments for the Development of Organs-on-Chips
                   3 Technological Advancements and New Products Launches
                   4 Growing Number of Partnerships and Collaborations Between Pharmaceutical Companies and Organs-on-Chips

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=144117291

Based on type, the organs-on-chips market is segmented into liver, lung, heart, kidney, and other organs-on-chips. In 2017, the accessories segment is expected to account for the largest share of the organs-on-chips market. The large share of this segment can be attributed to the simplicity of this model and the ability of on-chip hepatic tissues to maintain metabolic activity and phenotype similar to the in vivo environment.

Based on application, the organs-on-chips market is segmented into physiological model development, drug discovery, and toxicology research. The drug discovery segment is expected to register the highest CAGR during the forecast period. The increasing focus on drug discovery, rising need for more predictive in vitro tools for drug development among pharmaceutical companies, and growing preference for alternatives to conventional cell culture and animal models are some of the factors that are driving the growth of the drug discovery segment.

Geographical Analysis:-

In 2017, North America is expected to dominate the market followed by Europe. The large share of this geographical segment is attributed to factors such as availability of new and advanced organs-on-chips in the market, and favorable government initiatives in terms of funding and programs for basic drug development and research, and the presence of key pharmaceutical companies. These are regions where the majority of drug development activity is concentrated.

Read more: - https://www.marketsandmarkets.com/PressReleases/organs-on-chips.asp

Top Key Players:-

The organs-on-chips market is emerging and high growth potential market with the presence of several small players and startups firms. Some of the players in the organs-on-chips market include Emulate (US), CN Bio (UK), TissUse (Germany), Mimetas (Netherlands), InSphero (Switzerland), Ascendance Bio (US), Kirkstall (UK), HUREL (HUREL) (US), SynVivo (US), AxoSim (US), and Nortis (US).

Research Antibodies & Reagents Market by Product and Technology - 2022

Factors such as the increasing R&D activities and expenditure in the life science industry, increasing funding for proteomics research and drug discovery, and the growing collaboration between industries and academic institutes are the key drivers of the research antibodies market. However, the quality concerns over research antibodies (with respect to research reproducibility), cost- and time- intensive antibody development processes, and the pricing pressures faced by prominent market players are the major challenges currently at play in the market.

The Research Antibodies Market (including reagents) is expected to reach USD 12.60 Billion by 2022 from an estimated USD 9.33 Billion in 2017, at a CAGR of 6.2% during the forecast period.

Major Market Developments

• In January 2017, Merck expanded its end-to-end bio-development centers in North America, China, and Europe to meet increasing customer demand and also to increase its manufacturing capabilities.
• In March 2016, Thermo Fisher Scientific (US) acquired Affymetrix, Inc. (US) expanding the company’s research antibody portfolio, and strengthening its leadership in the biosciences business. It also helped Thermo Fisher add new genetic analysis capabilities in the clinical and applied markets.
• In April 2016, Abcam launched a suite of immunoassay, products based on recombinant monoclonal antibody pairs used in ELISA to study secreted biomarkers by life science researchers

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownload.asp?id=94212793
On the basis of product, the reagents segment accounted for the largest share of the global research antibodies market (including reagents), in 2016. This can be attributed to the fact that a large number of reagents are used in various routine assays and techniques.
Based on technology, the western blotting segment accounted for the largest share of the research antibodies market. Its ability to quantify as little as 0.1 nanograms of protein in a sample with high specificity makes it an indispensable tool in proteomic research; this is the key factor driving market growth.

Based on application, the proteomics segment accounted for the largest share of the research antibodies market. The large share of this segment is attributed to the deployment of proteomic-based approaches in biomarker detection and cancer profiling, increasing R&D expenditure, and availability of funds from various organizations.

Based on end user, the pharmaceutical & biotechnological companies segment accounted for the largest share of the research antibodies market owing to the high uptake of research-specific antibodies in the drug discovery and development process, along with the increasing use of these research tools in the ever-developing proteomics research sector.

Know more: - https://www.marketsandmarkets.com/PressReleases/research-antibodies-reagents.asp  

Regional Analysis:-
North America accounted for the largest share of the research antibodies market in 2016, followed by Europe. This regional segment shows significant market growth opportunities owing to the increasing research activities in the fields of proteomics and genomics, favorable government funding initiatives, and the growing focus of stakeholders on research projects.

Emerging Trends and Global Future Forecast of Medical Suction Devices Market

Major factors driving the growth of this market the paradigm shift from traditional healthcare settings to home healthcare and the increasing need for compact and portable devices. Moreover, the rising adoption of home care has led to the increased demand of portable suction devices, as they are reliable & easy to use and have high durability & robustness.

The global Medical Suction Devices Market is expected to reach USD 886.3 Million by 2020 from
USD 732.0 Million in 2015, at a CAGR of 3.9% during the forecast period.

The report segments the medical suction devices market based on type, portability, applications, end user, and region. On the basis of type, the medical suction devices market is segmented into AC-powered devices, battery–powered devices, dual-powered devices and manually operated devices. AC-powered devices segment is expected to dominate the market by holding largest share in 2015.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=100130488

The dual-powered devices segment is expected to grow at highest growth rate. The high growth in this segment is attributed to the increasing homecare market and growing number of prehospitals and emergency care settings worldwide.

Among applications the surgical applications dominate the market whereas the research and diagnostic applications segment is expected to grow at highest CAGR during the forecast period. Among the portability segment the wall-mounted device are expected to dominate the market in 2015 and is projected to grow at highest CAGR during the forecast period. Among end users, the hospitals and clinics segment is expected to dominate the market during the forecast period.

Regional Analysis:-
On the basis of region, the medical suction devices market is segmented into North America, Europe, Asia-Pacific, RoW. North America is expected to account for the largest share of this market in 2015. However, the Asian market is expected to grow at the highest CAGR, mainly due to growth in its aging population and the consequent increase in home care, and the rising prevalence of chronic diseases are responsible for growth of medical suction devices market in Asia-Pacific region. Furthermore, the increasing focus of prominent players on APAC is another factor driving the growth of this market.

Read More: - https://www.marketsandmarkets.com/PressReleases/medical-suction-device.asp

Top Key players:-
The medical suction devices market is highly competitive, with presence of several big as well as emerging market players. In addition, each product segment has a different set of vendors. Key market players Allied Healthcare Products Inc. (U.S.), ATMOS MedizinTechnik GmbH & Co. KG (Germany), Drive Medical (U.S.), INTEGRA Biosciences (Switzerland), Medela Holding AG (Switzerland), Medicop (Slovenia), Precision Medical, Inc. (U.S.), SSCOR, Inc. (U.S.), ZOLL Medical Corporation (U.S.), Weinmann Geräte für Medizin GmbH + Co. KG (Germany), Laerdal Medical (Norway), MG Electric Ltd (Colchester), Labconco Corporation (U.S.), Welch Vacuum (U.S.), Amsino International Inc. (U.S.) and Olympus Corporation (Japan).